summary
Introduced
11/04/2021
11/04/2021
In Committee
11/04/2021
11/04/2021
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To implement the recommendations of the Inspector General of the Department of Defense with respect to mitigation of foreign suppliers in the pharmaceutical supply chain of the Department of Defense.
AI Summary
This bill aims to strengthen the Department of Defense's (DoD) supply chains, particularly for pharmaceuticals. It requires the Under Secretary of Defense for Acquisition and Sustainment to develop risk management guidance for all DoD supply chains, identify gaps in information regarding reliance on foreign drug suppliers, and submit a report to Congress on vulnerabilities and recommendations to address them. Additionally, the bill directs the Director of the Defense Health Agency to develop guidance for risk management in the DoD's pharmaceutical supply chain, establish a working group to assess risks and identify critical pharmaceuticals, and create policies for allocating scarce resources in case of disruptions. Finally, the bill modifies Defense Logistics Agency instructions to require annual responsiveness testing of contingency contracts for pharmaceuticals and include the results in the Warstopper Program's annual reports.
Committee Categories
Military Affairs and Security
Sponsors (2)
Last Action
Read twice and referred to the Committee on Armed Services. (on 11/04/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/senate-bill/3174/all-info |
| BillText | https://www.congress.gov/117/bills/s3174/BILLS-117s3174is.pdf |
| Bill | https://www.congress.gov/117/bills/s3174/BILLS-117s3174is.pdf.pdf |
Loading...